# EDGAR Filing Document

**Accession Number:** 0001090872
**File Stem:** 0001193125-25-159100
**Filing Date:** 2025-7
**Character Count:** 11701
**Document Hash:** f361bdf6418c2e038d3edb49c6167ab6
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001193125-25-159100.hdr.sgml**: 20250715

**ACCESSION NUMBER**: 0001193125-25-159100

**CONFORMED SUBMISSION TYPE**: 8-K

**PUBLIC DOCUMENT COUNT**: 13

**CONFORMED PERIOD OF REPORT**: 20250711

**ITEM INFORMATION**: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

**ITEM INFORMATION**: Regulation FD Disclosure

**ITEM INFORMATION**: Financial Statements and Exhibits

**FILED AS OF DATE**: 20250715

**DATE AS OF CHANGE**: 20250715

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** AGILENT TECHNOLOGIES, INC.
- **CENTRAL INDEX KEY:** 0001090872
- **STANDARD INDUSTRIAL CLASSIFICATION:** LABORATORY ANALYTICAL INSTRUMENTS [3826]
- **ORGANIZATION NAME:** 08 Industrial Applications and Services
- **EIN:** 770518772
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1031

**FILING VALUES:**
- **FORM TYPE:** 8-K
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-15405
- **FILM NUMBER:** 251123227

**BUSINESS ADDRESS:**
- **STREET 1:** 5301 STEVENS CREEK BLVD
- **CITY:** SANTA CLARA
- **STATE:** CA
- **ZIP:** 95051
- **BUSINESS PHONE:** (408) 345-8886

**MAIL ADDRESS:**
- **STREET 1:** 5301 STEVENS CREEK BLVD, MS 1A-LC
- **STREET 2:** P.O. BOX 58059
- **CITY:** SANTA CLARA
- **STATE:** CA
- **ZIP:** 95052-8059

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** AGILENT TECHNOLOGIES INC
- **DATE OF NAME CHANGE:** 19990816

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** HP MEASUREMENT INC
- **DATE OF NAME CHANGE:** 19990716

?xml version='1.0' encoding='ASCII'? 8-K

### UNITED STATES

### SECURITIES AND EXCHANGE COMMISSION

#### Washington, D.C. 20549

### FORM 8-K

#### CURRENT REPORT

#### Pursuant to Section 13 or 15(d)

#### of The Securities Exchange Act of 1934

#### Date of Report (Date of earliest event reported): July 11, 2025

## AGILENT TECHNOLOGIES, INC.

#### (Exact name of registrant as specified in its charter)

---

| | | |
|:---|:---|:---|
| **Delaware** | **001-15405** | **77-0518772** |
| **(State or other jurisdiction**<br> **of incorporation)** | **(Commission**<br> **File Number)** | **(IRS Employer**<br> **Identification No.)** |

---

#### 5301 Stevens Creek Boulevard, Santa Clara, CA 95051

#### (Address of Principal Executive Offices) (Zip Code)

#### Registrant's telephone number, including area code (800) 227-9770

#### (Former name or former address, if changed since last report.)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

---

| | |
|:---|:---|
| **TITLE OF EACH CLASS** | **NAME OF EACH EXCHANGE**<br> **ON WHICH REGISTERED** |
| COMMON STOCK, $0.01 PAR VALUE | New York Stock Exchange |

---

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter). Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

------

---

| | |
|:---|:---|
| **Item 5.02** | **Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.**  |

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) On July 11, 2025, Robert W. McMahon, informed Agilent Technologies, Inc. ("Agilent") that he would resign from his position as Agilent's Senior Vice President, Chief Financial Officer, effective July 31, 2025. Mr. McMahon's departure is not related to any disagreement with Agilent on any matter relating to its accounting practices, financial statements, internal controls, or operations.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c) On July 14, 2025, Agilent appointed Rodney Gonsalves as interim Chief Financial Officer and interim Principal Financial Officer of Agilent, effective as of July 31, 2025. Mr. Gonsalves will continue to serve as Agilent's Vice President, Corporate Controller and Principal Accounting Officer. Mr. Gonsalves' biographical information can be found in Agilent's annual report on Form 10-K for the year ended October 31, 2024 filed with the Securities and Exchange Commission on December 20, 2024. There are no related party transactions involving Mr. Gonsalves that are reportable under Item 404(a) of Regulation S-K.

---

| | |
|:---|:---|
| **Item 7.01** | **Regulation FD Disclosure.**  |

---

On July 15, 2025, Agilent issued a press release announcing Mr. McMahon's departure and Mr. Gonsalves' appointment. A copy of the press release is attached as Exhibit 99.1 hereto.

---

| | |
|:---|:---|
| **Item 9.01.** | **Financial Statements and Exhibits.**  |

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d) Exhibits

The following is furnished as an exhibit to this report and shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended:

---

| | |
|:---|:---|
| **Exhibit No.** | **Description** |
| 99.1 | [Press release dated July 15, 2025.](d866414dex991.htm) |
| 104 | Cover page interactive data file (embedded within the Inline XBRL document). |

---

------

#### SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

---

| | | |
|:---|:---|:---|
|  | AGILENT TECHNOLOGIES, INC. | AGILENT TECHNOLOGIES, INC. |
|  | By: | /s/ P. Diana Chiu |
|  | Name: | P. Diana Chiu |
|  | Title: | Vice President, Assistant General Counsel<br> and Assistant Secretary |
| Date: July 15, 2025 |  |  |

---

## Exhibit 99.1

**Exhibit 99.1** 

**Agilent Announces CFO Transition** 

**SANTA CLARA, California, July 15, 2025** — Agilent Technologies Inc. (NYSE: A) today announced that effective July 31, Senior Vice President and Chief Financial Officer Bob McMahon will step down from his role as he relocates to the East Coast for family reasons and prepares for the next chapter in his career.

Following McMahon's departure, <u>Rodney Gonsalves</u>, Agilent's current corporate controller and principal accounting officer, will additionally serve as interim CFO until McMahon's successor is named.

"I want to sincerely thank Bob for his seven impactful years of service at Agilent. His leadership and contributions have played an important role in our company's growth, and we wish him the best in his future endeavors," said President and CEO Padraig McDonnell. "Additionally, we are confident in Rodney's demonstrated decades-long leadership in multiple senior finance-management roles as we complete a timely and thorough global search for our next CFO with the support of a leading executive search firm."

Agilent will release financial results for the third quarter of fiscal year 2025 after the stock market closes on Wednesday, Aug. 27, 2025. In addition, the company will host a conference call to discuss the results at 1:30 p.m. Pacific that same day. Agilent expects its financial results for the third quarter of fiscal year 2025 to be within the guidance range it previously provided. Agilent remains confident in its long-term plans.

**About Agilent Technologies**

Agilent Technologies Inc. (NYSE: A) is a global leader in analytical and clinical laboratory technologies, delivering insights and innovation that help our customers bring great science to life. Agilent's full range of solutions includes instruments, software, services, and expertise that provide trusted answers to our customers' most challenging questions. The company generated revenue of $6.51 billion in fiscal year 2024 and employs approximately 18,000 people worldwide. Information about Agilent is available at <u>www.agilent.com</u>. To receive the latest Agilent news, subscribe to the <u>Agilent Newsroom</u>.

------

Follow Agilent on <u>LinkedIn</u> and <u>Facebook</u>.

**Forward-Looking Statements** 

This news release contains forward-looking statements as defined in the Securities Exchange Act of 1934 and is subject to the safe harbors created therein. The forward-looking statements contained herein include, but are not limited to, information regarding Agilent's growth prospects, business, financial results, revenue, non-GAAP earnings guidance for the third quarter and full fiscal year 2025, and the effects of its new organizational structure, operational transformation and market-focused strategy. These forward-looking statements involve risks and uncertainties that could cause Agilent's results to differ materially from management's current expectations. Such risks and uncertainties include, but are not limited to, unforeseen changes in the strength of Agilent's customers' businesses; unforeseen changes in the demand for current and new products, technologies, and services; unforeseen changes in the currency markets; customer purchasing decisions and timing; and the risk that Agilent is not able to realize the savings expected from integration and restructuring activities. In addition, other risks that Agilent faces in running its operations include the ability to execute successfully through business cycles; the ability to meet and achieve the benefits of its operational transformation, market-focused strategy and cost-reduction goals and otherwise successfully adapt its cost structures to continuing changes in business conditions; ongoing competitive, pricing and gross-margin pressures; the risk that its cost-cutting initiatives will impair its ability to develop products and remain competitive and to operate effectively; the impact of geopolitical uncertainties and global economic conditions on its operations, its markets and its ability to conduct business; the ability to improve asset performance to adapt to changes in demand; the impact relating to or arising from changes to tariffs, import/export or trade policies; the ability of its supply chain to adapt to changes in demand; the ability to successfully introduce new products at the right time, price and mix; the ability of Agilent to successfully integrate recent acquisitions; the ability of Agilent to successfully comply with certain complex regulations; and other risks detailed in Agilent's filings with the Securities and Exchange Commission, including its quarterly report on Form 10-Q for the fiscal quarter ended April 30, 2025. Forward-looking statements are based on the beliefs and assumptions of Agilent's management and on currently available information. Agilent undertakes no responsibility to publicly update or revise any forward-looking statement.

\# \# \#

**Investor Contact:** 

Parmeet Ahuja

+1 408-345-8948

<u>parmeet_ahuja@agilent.com</u> 

------

**Media Contact:** 

Andréa Topper

+1 408-709-0060

<u>andrea.topper@agilent.com</u>